搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Arabidopsis thaliana Ubiquitin carboxyl-terminal hydrolase 20 (UBP20), partial CSB-YP875524DOA
CSB-EP875524DOA
CSB-BP875524DOA
CSB-MP875524DOA
CSB-EP875524DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana 5'-3' exoribonuclease 2 (XRN2), partial CSB-YP875525DOA
CSB-EP875525DOA
CSB-BP875525DOA
CSB-MP875525DOA
CSB-EP875525DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays Glutathione transferase GST 23 CSB-YP875526ZAX
CSB-EP875526ZAX
CSB-BP875526ZAX
CSB-MP875526ZAX
CSB-EP875526ZAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Arabidiol synthase (PEN1), partial CSB-YP875527DOA
CSB-BP875527DOA
CSB-MP875527DOA
CSB-EP875527DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Transcription factor MEE8 (MEE8) CSB-YP875528DOA
CSB-EP875528DOA
CSB-BP875528DOA
CSB-MP875528DOA
CSB-EP875528DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Pentatricopeptide repeat-containing protein At1g08610 (At1g08610), partial CSB-YP875529DOA
CSB-EP875529DOA
CSB-BP875529DOA
CSB-MP875529DOA
CSB-EP875529DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative ribosome-inactivating protein CSB-YP875530COAN
CSB-EP875530COAN
CSB-BP875530COAN
CSB-MP875530COAN
CSB-EP875530COAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ruta graveolens Chalcone synthase 2 (CHS2) CSB-YP875531RIY
CSB-EP875531RIY
CSB-BP875531RIY
CSB-MP875531RIY
CSB-EP875531RIY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 30S ribosomal protein S4, chloroplastic (rps4) CSB-YP875532PNAM
CSB-EP875532PNAM
CSB-BP875532PNAM
CSB-MP875532PNAM
CSB-EP875532PNAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Fasciclin-like arabinogalactan protein 15 (FLA15) CSB-YP875533DOA
CSB-EP875533DOA
CSB-BP875533DOA
CSB-MP875533DOA
CSB-EP875533DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana ATP-dependent DNA helicase Q-like 3 (RECQL3), partial CSB-YP875534DOA
CSB-EP875534DOA
CSB-BP875534DOA
CSB-MP875534DOA
CSB-EP875534DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable 3-beta-hydroxysteroid-Delta (8),Delta (7)-isomerase (Os01g0103600, LOC_Os01g01369), partial CSB-YP875535OFG1
CSB-EP875535OFG1
CSB-BP875535OFG1
CSB-MP875535OFG1
CSB-EP875535OFG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana DNA repair helicase XPB2 (XPB2), partial CSB-YP875536DOA
CSB-EP875536DOA
CSB-BP875536DOA
CSB-MP875536DOA
CSB-EP875536DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays Homocysteine S-methyltransferase 3 (HMT-3) CSB-YP875537ZAX
CSB-EP875537ZAX
CSB-BP875537ZAX
CSB-MP875537ZAX
CSB-EP875537ZAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Glutathione S-transferase U17 (GSTU17) CSB-YP875538DOA
CSB-EP875538DOA
CSB-BP875538DOA
CSB-MP875538DOA
CSB-EP875538DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Peptide deformylase 1B, chloroplastic (PDF1B) CSB-YP875539DOA
CSB-EP875539DOA
CSB-BP875539DOA
CSB-MP875539DOA
CSB-EP875539DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Solanum lycopersicum Peptide deformylase 1B, chloroplastic (PDF1B), partial CSB-YP875540SZY
CSB-EP875540SZY
CSB-BP875540SZY
CSB-MP875540SZY
CSB-EP875540SZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Glutamyl-tRNA (Gln) amidotransferase subunit B, chloroplastic/mitochondrial (GATB), partial CSB-YP875541DOA
CSB-EP875541DOA
CSB-BP875541DOA
CSB-MP875541DOA
CSB-EP875541DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Petunia hybrida Actin-depolymerizing factor 2 (ADF2) CSB-YP875542EUD
CSB-EP875542EUD
CSB-BP875542EUD
CSB-MP875542EUD
CSB-EP875542EUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Flavin-containing monooxygenase YUCCA10 (YUC10) CSB-YP875543DOA
CSB-EP875543DOA
CSB-BP875543DOA
CSB-MP875543DOA
CSB-EP875543DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>